Louvain-la-Neuve, Belgium, and Barcelona, Spain, April 20, 2018 – IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy solutions for the treatment of cancer, will demonstrate how to secure the performance, the investment and the future of establishing a proton therapy center at the 37th Annual European Society for Radiotherapy & Oncology (ESTRO) Meeting and Exhibition being held in Barcelona from 20-24 April, 2018.
Proton therapy is considered to be one of the most advanced forms of radiation therapy. When investing in a technology that will last for over 30 years, the selection of the right partner is a crucial step in the buying process. During the ESTRO meeting, proton therapy practitioners will share their experience about securing, installing and operating a proton therapy center with IBA during open sessions on the IBA booth as well as at the IBA Symposium. Aiming to offer seamlessly integrated proton therapy solutions, IBA will showcase the latest advances in its partnerships with the best leaders in radiation oncology at its booth, #1400.
Latest news from proton therapy practitioners
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Securing the performance in proton therapy
After a fast installation of the Proteus®PLUS* solution by IBA, the University Medical Center Groningen (UMCG) Proton Therapy Center successfully treated the first patient in The Netherlands in January 2018 and announces today the acceptance of the center's second proton therapy room. Benefiting from a series of some of the world's most advanced technology in proton therapy, the number of patients being treated at the center is ramping up quickly and will continue to rise with the additional treatment capacity.
Stefan Both, Professor & Head of Medical Physics at UMCG, will share his experience of UMCG's path towards a SMART Proton Pencil Beam Scanning Clinic on the IBA booth, #1400 on Saturday, April 21st, from 10:00 AM to 10:30 AM.
Securing the investment in proton therapy
On April 11th, 2018, following a record nine month installation program by IBA, Proton Partners International announced it has treated the first patient in the UK with high energy proton beam therapy. The first patient was treated on the Proteus®ONE* solution at Rutherford Cancer Centre in Newport, South Wales. The patients benefit from the latest Intensity Modulated Proton Therapy (IMPT) to adjust the depth and intensity of the beam to the shape of the tumor. Proteus®ONE solution includes Pencil Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities making Proteus®ONE the only compact solution ready for adaptive treatment. Proton Partners International plans to build eight centers in the UK to provide a treatment center within 90 minutes of any patient's home.
